CAR T-cell medicinessecondary malignancies of T-cell originEuropean Medicines Agency
…Abstract Overview of: European Medicines Agency. CAR T-cell medicines: PRAC identifies risk of secondary malignancies of T-cell origi…
1articles mentioning drugs
1drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: CAR T-cell medicines ×
CAR T-cell medicines
This drug is selected. Its supporting articles are shown below.